Prima BioMed Ltd (PBMD) Gains as Analyst Sees Over 400% Upside
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
After-Hours Stock Movers 12/30: (PBMD) (CMRX) Higher; (AEZS) Lower (more...)
December 30, 2015 5:56 PM ESTPrima Biomed (NASDAQ: PBMD) 6.3% HIGHER; Roth Capital initiates coverage with a Buy rating and a price target of $6.00.
Chimerix (NASDAQ: CMRX) 4.4% HIGHER; In a 13G filing Steven... More
Roth Capital Starts Prima Biomed (PBMD) at Buy; $6 PT
December 30, 2015 4:37 PM ESTRoth Capital initiates coverage on Prima Biomed (NASDAQ: PBMD) with a Buy rating and a price target of $6.00.
Analyst Joseph Pantginis commented, "We are initiating coverage of Prima with a Buy rating and $6 price target. We believe Prima is in a leading position... More
